Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat. 2005

Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.

The aim of the current study was to investigate whether, and if so how, brain-derived neurotrophic factor (BDNF) acts to develop the spinal sensitization underlying inflammation-induced hyperalgesia. In spinal cord slice preparations from rats with inflammation induced by complete Freund's adjuvant (CFA), BDNF, but not nerve growth factor (NGF) or neurotrophin-3 (NT-3), acted presynaptically to increase the frequency of excitatory miniature EPSCs in substantia gelatinosa (SG) neurones of the CFA-treated, but not untreated rats, through activation of lidocaine (lignocaine)-sensitive, TTX-resistant Na+ channels. This effect was observed in the spinal cord slices of the CFA-treated rat only 2-4 days after the CFA injection. On the other hand, the number of monosynaptic Abeta afferent inputs to the SG significantly increased 1 week after the onset of the inflammation, and this increase was significantly suppressed by treatment with anti-BDNF antiserum administered 1 day before and just after the CFA injection. In addition, the treatment with anti-BDNF antiserum significantly attenuated the CFA-induced hyperalgesia and/or allodynia. These findings, taken together, suggest that BDNF, which is considered to be released from the sensitized primary afferents, increases the excitability of SG neurones through its action on the presynaptic terminals. BDNF may thereafter induce monosynaptic Abeta afferents to the SG, thereby developing hyperalgesia and/or allodynia during inflammation.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D009187 Myelitis Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction. Myelopathy, Inflammatory,Spinal Cord Inflammation,Subacute Necrotizing Myelitis,Infectious Myelitis,Inflammation, Spinal Cord,Inflammations, Spinal Cord,Inflammatory Myelopathies,Inflammatory Myelopathy,Myelitides,Myelitides, Subacute Necrotizing,Myelitis, Infectious,Myelitis, Subacute Necrotizing,Myelopathies, Inflammatory,Necrotizing Myelitides, Subacute,Necrotizing Myelitis, Subacute,Spinal Cord Inflammations,Subacute Necrotizing Myelitides
D009414 Nerve Growth Factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. Neurite Outgrowth Factor,Neurite Outgrowth Factors,Neuronal Growth-Associated Protein,Neuronotrophic Factor,Neurotrophic Factor,Neurotrophic Factors,Neurotrophin,Neurotrophins,Growth-Associated Proteins, Neuronal,Neuronal Growth-Associated Proteins,Neuronotrophic Factors,Neurotrophic Protein,Neurotrophic Proteins,Proteins, Neuronal Growth-Associated,Factor, Neurite Outgrowth,Factor, Neuronotrophic,Factor, Neurotrophic,Factors, Nerve Growth,Factors, Neurite Outgrowth,Factors, Neuronotrophic,Factors, Neurotrophic,Growth Associated Proteins, Neuronal,Growth-Associated Protein, Neuronal,Neuronal Growth Associated Protein,Neuronal Growth Associated Proteins,Outgrowth Factor, Neurite,Outgrowth Factors, Neurite,Protein, Neuronal Growth-Associated
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009475 Neurons, Afferent Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM. Afferent Neurons,Afferent Neuron,Neuron, Afferent
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D005727 Ganglia, Spinal Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. Dorsal Root Ganglia,Spinal Ganglia,Dorsal Root Ganglion,Ganglion, Spinal,Ganglia, Dorsal Root,Ganglion, Dorsal Root,Spinal Ganglion
D006930 Hyperalgesia An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve. Hyperalgesia, Tactile,Hyperalgesia, Thermal,Hyperalgia,Hyperalgia, Mechanical,Hyperalgia, Primary,Hyperalgia, Secondary,Allodynia,Allodynia, Mechanical,Allodynia, Tactile,Allodynia, Thermal,Hyperalgesia, Mechanical,Hyperalgesia, Primary,Hyperalgesia, Secondary,Hyperalgesic Sensations,Mechanical Allodynia,Mechanical Hyperalgesia,Tactile Allodynia,Thermal Allodynia,Allodynias,Hyperalgesias,Hyperalgesias, Thermal,Hyperalgesic Sensation,Mechanical Hyperalgia,Mechanical Hyperalgias,Primary Hyperalgia,Primary Hyperalgias,Secondary Hyperalgia,Secondary Hyperalgias,Sensation, Hyperalgesic,Sensations, Hyperalgesic,Thermal Hyperalgesia

Related Publications

Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
June 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
February 2012, Experimental neurology,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
October 2014, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
July 1999, Proceedings of the National Academy of Sciences of the United States of America,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
January 2015, Transactions of the American Clinical and Climatological Association,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
January 2010, Mediators of inflammation,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
February 2017, Experimental neurology,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
August 1997, Brain research,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
July 2019, Biological psychiatry,
Satoru Matayoshi, and Nan Jiang, and Toshihiko Katafuchi, and Kohei Koga, and Hidemasa Furue, and Toshiharu Yasaka, and Terumasa Nakatsuka, and Xin-Fu Zhou, and Yasuhiko Kawasaki, and Nobuyuki Tanaka, and Megumu Yoshimura
April 2012, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!